公开(公告)号：US12285483B2

公开(公告)日：2025-04-29

申请号：US18269284

申请日：2021-10-16

Applicant: ACCESS TO ADVANCED HEALTH INSTITUTE

Inventor： Christopher Bradford Fox

IPC: A61K39/39 ,  A61K9/10 ,  A61K9/107 ,  A61K39/145 ,  A61K47/22 ,  A61P37/04 ,  A61K39/00

Abstract: This disclosure describes the use of solanesol as an adjuvant in vaccine compositions, as well as related prophylactic and therapeutic methods. Solanesol may be used to replace squalene in vaccine compositions with similar or superior immunostimulatory effects. Solanesol, which is solid at room temperature, may be formulated for use in vaccine compositions by heating above its melting temperature in an aqueous solution to form a dispersion.